ArticleCancers2023

Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers.

Dominik Dannehl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.